SK284991B6 - Dihydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents

Dihydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDF

Info

Publication number
SK284991B6
SK284991B6 SK1490-2001A SK14902001A SK284991B6 SK 284991 B6 SK284991 B6 SK 284991B6 SK 14902001 A SK14902001 A SK 14902001A SK 284991 B6 SK284991 B6 SK 284991B6
Authority
SK
Slovakia
Prior art keywords
dihydrate
hydrochloride dihydrate
diabetes mellitus
pyridyl
provides
Prior art date
Application number
SK1490-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK14902001A3 (sk
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK14902001A3 publication Critical patent/SK14902001A3/sk
Publication of SK284991B6 publication Critical patent/SK284991B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK1490-2001A 1999-04-20 2000-04-19 Dihydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie SK284991B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001521 WO2000063205A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (2)

Publication Number Publication Date
SK14902001A3 SK14902001A3 (sk) 2002-02-05
SK284991B6 true SK284991B6 (sk) 2006-04-06

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1490-2001A SK284991B6 (sk) 1999-04-20 2000-04-19 Dihydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie

Country Status (42)

Country Link
EP (2) EP1411055A1 (ja)
JP (2) JP4283449B2 (ja)
KR (1) KR100601244B1 (ja)
CN (2) CN101134756A (ja)
AP (1) AP1562A (ja)
AR (2) AR023562A1 (ja)
AT (1) ATE268770T1 (ja)
AU (2) AU4130900A (ja)
BG (1) BG65864B1 (ja)
BR (1) BR0009897A (ja)
CA (1) CA2382036A1 (ja)
CO (1) CO5170422A1 (ja)
CZ (1) CZ300653B6 (ja)
DE (1) DE60011419T2 (ja)
DK (1) DK1173436T3 (ja)
DZ (1) DZ3162A1 (ja)
EA (1) EA004232B1 (ja)
EG (1) EG24063A (ja)
ES (1) ES2218146T3 (ja)
GB (1) GB9909041D0 (ja)
HK (1) HK1045151B (ja)
HR (1) HRP20010770B1 (ja)
HU (1) HUP0200865A3 (ja)
IL (1) IL146078A0 (ja)
MA (1) MA26783A1 (ja)
MX (1) MXPA01010696A (ja)
MY (1) MY126034A (ja)
NO (1) NO320609B1 (ja)
NZ (1) NZ515166A (ja)
OA (1) OA11866A (ja)
PE (1) PE20010050A1 (ja)
PL (1) PL351135A1 (ja)
PT (1) PT1173436E (ja)
RS (1) RS50136B (ja)
SI (1) SI1173436T1 (ja)
SK (1) SK284991B6 (ja)
TR (1) TR200103040T2 (ja)
TW (1) TWI277616B (ja)
UA (1) UA71615C2 (ja)
UY (1) UY26112A1 (ja)
WO (1) WO2000063205A2 (ja)
ZA (1) ZA200108720B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DE60217168T2 (de) * 2001-11-21 2007-10-04 Smithkline Beecham Plc, Brentford 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1411055A1 (en) 2004-04-21
YU81501A (sh) 2004-07-15
ATE268770T1 (de) 2004-06-15
JP2009143954A (ja) 2009-07-02
IL146078A0 (en) 2002-07-25
HUP0200865A2 (en) 2002-08-28
RS50136B (sr) 2009-03-25
HUP0200865A3 (en) 2005-04-28
KR100601244B1 (ko) 2006-07-19
ES2218146T3 (es) 2004-11-16
TR200103040T2 (tr) 2002-04-22
EG24063A (en) 2008-05-08
UA71615C2 (uk) 2004-12-15
CO5170422A1 (es) 2002-06-27
SI1173436T1 (en) 2004-12-31
DE60011419D1 (de) 2004-07-15
MXPA01010696A (es) 2002-06-04
KR20010110791A (ko) 2001-12-13
BR0009897A (pt) 2002-04-16
JP4283449B2 (ja) 2009-06-24
NO320609B1 (no) 2005-12-27
AU765911B2 (en) 2003-10-02
PL351135A1 (en) 2003-03-24
NZ515166A (en) 2004-02-27
AR023562A1 (es) 2002-09-04
NO20015104D0 (no) 2001-10-19
HRP20010770B1 (en) 2005-06-30
ZA200108720B (en) 2002-11-28
MA26783A1 (fr) 2004-12-20
HK1045151B (zh) 2005-03-18
DE60011419T2 (de) 2005-06-16
AP1562A (en) 2006-02-01
TWI277616B (en) 2007-04-01
DK1173436T3 (da) 2004-09-27
EP1173436B1 (en) 2004-06-09
HK1045151A1 (en) 2002-11-15
GB9909041D0 (en) 1999-06-16
CN101134756A (zh) 2008-03-05
WO2000063205A2 (en) 2000-10-26
WO2000063205A3 (en) 2001-01-25
EA200101101A1 (ru) 2002-04-25
PE20010050A1 (es) 2001-03-10
DZ3162A1 (fr) 2000-10-26
AU4130900A (en) 2000-11-02
JP2002542242A (ja) 2002-12-10
EA004232B1 (ru) 2004-02-26
BG106112A (bg) 2002-05-31
CZ300653B6 (cs) 2009-07-08
CA2382036A1 (en) 2000-10-26
AR023566A1 (es) 2002-09-04
CN1327447A (zh) 2001-12-19
MY126034A (en) 2006-09-29
AP2001002331A0 (en) 2000-04-19
AU2755202A (en) 2002-05-16
UY26112A1 (es) 2000-12-29
NO20015104L (no) 2001-12-19
HRP20010770A2 (en) 2002-10-31
BG65864B1 (bg) 2010-03-31
EP1173436A2 (en) 2002-01-23
OA11866A (en) 2006-03-02
PT1173436E (pt) 2004-10-29
SK14902001A3 (sk) 2002-02-05
CZ20013759A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
US20060189659A1 (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt
US6815457B1 (en) Thiazolidinedione derivative and its use as antidiabetic
US6806280B1 (en) Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt
JP2009143954A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
US6664278B2 (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
SK284990B6 (sk) Monohydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie
AU2754902A (en) Novel pharmaceutical

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110419